Proteins found in nature did not evolve specifically to treat diseases. Administering them directly as therapeutics often leads to less efficacious and less safe results. This is especially true when therapeutics need precise targeted delivery.
Theradaptive is developing ways to improve therapeutics delivery thus enhancing efficacy while reducing off target side effects.
Our work is motivated by the fact that millions of people are suffering from debilitating conditions related to loss of tissue function. We have an opportunity to directly impact their lives by developing therapeutics to treat their conditionsABOUT US
We have developed hundreds of material binding variants of various recombinant proteins for use in over a dozen clinical indications. These range from applications in spinal fusion and orthopedics, to soft tissue repair and targeted chemotherapeutics. Our modified proteins address current limitations and enable safer and long-term delivery.